×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INZY – inozyme pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INZY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
09:13 am
inzy
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines [Yahoo! Finance]
Medium
Report
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines [Yahoo! Finance]
12/12
08:11 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $26.00 price target on the stock.
Medium
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $26.00 price target on the stock.
11/27
08:30 am
inzy
Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/13
11:16 am
inzy
Here's Why Inozyme Pharma (INZY) is Poised for a Turnaround After Losing -29.98% in 4 Weeks [Yahoo! Finance]
Medium
Report
Here's Why Inozyme Pharma (INZY) is Poised for a Turnaround After Losing -29.98% in 4 Weeks [Yahoo! Finance]
11/11
08:30 am
inzy
Inozyme Pharma to Present at Upcoming Investor Conferences
Low
Report
Inozyme Pharma to Present at Upcoming Investor Conferences
11/6
08:07 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
11/6
08:07 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
11/5
06:24 pm
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
04:15 pm
inzy
Form SC 13G Inozyme Pharma, Inc. Filed by: Affinity Asset Advisors, LLC
Medium
Report
Form SC 13G Inozyme Pharma, Inc. Filed by: Affinity Asset Advisors, LLC
11/14
12:20 pm
inzy
Form SC 13G/A Inozyme Pharma, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Medium
Report
Form SC 13G/A Inozyme Pharma, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
11/8
02:19 pm
inzy
Form SC 13G Inozyme Pharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Inozyme Pharma, Inc. Filed by: BlackRock, Inc.
11/5
08:34 am
inzy
Form 10-Q Inozyme Pharma, Inc. For: Sep 30
Medium
Report
Form 10-Q Inozyme Pharma, Inc. For: Sep 30
11/5
08:32 am
inzy
Form 8-K Inozyme Pharma, Inc. For: Nov 05
Medium
Report
Form 8-K Inozyme Pharma, Inc. For: Nov 05
10/24
04:34 pm
inzy
Form 8-K Inozyme Pharma, Inc. For: Oct 24
Medium
Report
Form 8-K Inozyme Pharma, Inc. For: Oct 24
10/24
02:02 pm
inzy
Form SC 13G Inozyme Pharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Inozyme Pharma, Inc. Filed by: BlackRock, Inc.
10/7
04:38 pm
inzy
Form 4 Inozyme Pharma, Inc. For: Oct 03 Filed by: Harris Erik
Low
Report
Form 4 Inozyme Pharma, Inc. For: Oct 03 Filed by: Harris Erik
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: